EAM
RYTM icon

EFG Asset Management’s Rhythm Pharmaceuticals RYTM Stock Holding History

EFG Asset Management’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$2.05M Buy
+20,269
New +$1.88M 0.26% 142

Other funds holding RYTM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

EFG Asset Management's RYTM Position: Q3 2025 in Review

EFG Asset Management opened a new position in Rhythm Pharmaceuticals (RYTM) in Q3 2025: 20,269 shares worth $2.05M. The stake represents 0.26% of the portfolio and ranks #142 among its holdings.

264 funds tracked by Wall St. Rank hold RYTM as of Q3 2025.

  • EFG Asset Management held 20,269 shares of Rhythm Pharmaceuticals worth $2.05M as of Q3 2025.
  • Rhythm Pharmaceuticals was a new EFG Asset Management position in Q3 2025.
  • Rhythm Pharmaceuticals made up 0.26% of EFG Asset Management's portfolio in Q3 2025, its #142 holding.
  • 264 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q3 2025.

Based on EFG Asset Management's 13F filing for Q3 2025, filed 3 Nov 2025.